sábado, 17 de julio de 2021

FDA approves daratumumab and hyaluronidase-fihj with pomalidomide and dexamethasone for multiple myeloma | FDA

FDA approves daratumumab and hyaluronidase-fihj with pomalidomide and dexamethasone for multiple myeloma | FDA

No hay comentarios:

Publicar un comentario